prikaz prve stranice dokumenta Is there any association between plasma lipid profile and severity of COVID-19?
  Download
PDF 357.94 KB
Scientific paper - Original scientific paper
Is there any association between plasma lipid profile and severity of COVID-19?
Clinical Nutrition ESPEN, 49 (2022); 191-196. https://doi.org/10.1016/j.clnesp.2022.04.026
Rahimibashar, Farshid; Sedighi, Ladan; Shahriary, Alireza; Reiner, Željko; Pourhoseingholi, Mohamad Amin; Mirmomeni, Golshan; Jouzdani, Ali Fathi; Vahedian-Azimi, Amir; Jamialahmadi, Tannaz; Sahebkar, Amirhossein

Cite this document

Rahimibashar, F., Sedighi, L., Shahriary, A., Reiner, Ž., Pourhoseingholi, M. A., Mirmomeni, G. ... Sahebkar, A. (2022). Is there any association between plasma lipid profile and severity of COVID-19?. Clinical Nutrition ESPEN, 49., 191-196. doi: 10.1016/j.clnesp.2022.04.026

Rahimibashar, Farshid, et al. "Is there any association between plasma lipid profile and severity of COVID-19?." Clinical Nutrition ESPEN, vol. 49, 2022, pp. 191-196. https://doi.org/10.1016/j.clnesp.2022.04.026

Rahimibashar, Farshid, Ladan Sedighi, Alireza Shahriary, Željko Reiner, Mohamad Amin Pourhoseingholi, Golshan Mirmomeni, Ali Fathi Jouzdani, Amir Vahedian Azimi, Tannaz Jamialahmadi and Amirhossein Sahebkar. "Is there any association between plasma lipid profile and severity of COVID-19?." Clinical Nutrition ESPEN 49 (2022): 191-196. https://doi.org/10.1016/j.clnesp.2022.04.026

Rahimibashar, F., et al. (2022) 'Is there any association between plasma lipid profile and severity of COVID-19?', Clinical Nutrition ESPEN, 49, pp. 191-196. doi: 10.1016/j.clnesp.2022.04.026

Rahimibashar F, Sedighi L, Shahriary A, Reiner Ž, Pourhoseingholi MA, Mirmomeni G, and sur.. Is there any association between plasma lipid profile and severity of COVID-19?. Clinical Nutrition ESPEN [Internet]. 2022 June [cited 2024 April 19];49:191-196. doi: 10.1016/j.clnesp.2022.04.026

F. Rahimibashar, et al., "Is there any association between plasma lipid profile and severity of COVID-19?", Clinical Nutrition ESPEN, vol. 49, pp. 191-196, June 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:761856. [Accessed: 19 April 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Is there any association between plasma lipid profile and severity of COVID-19?
AuthorFarshid Rahimibashar
AuthorLadan Sedighi
AuthorAlireza Shahriary
AuthorŽeljko Reiner
AuthorMohamad Amin Pourhoseingholi
AuthorGolshan Mirmomeni
AuthorAli Fathi Jouzdani
AuthorAmir Vahedian-Azimi
AuthorTannaz Jamialahmadi
AuthorAmirhossein Sahebkar
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
Background: COVID-19 is an infectious disease which caused a pandemic with many diseases and fatalities. This new variant of coronavirus called SARS-CoV-2 and is primarily characterized by respiratory symptoms. There are some data indicating that LDL-cholesterol (LDL-C) as well as HDL-cholesterol (HDL-C) levels are inversely correlated to disease severity and could act as a predictor for disease progression and unfavorable prognosis. However, the results of some other studies do not confirm this. This current study aimed to provide an answer to this question. ----- Methods: This prospective, single-center study analyzed 367 confirmed COVID-19 patients to find whether there are any differences in plasma lipoproteins between survivors and non-survivors patients or between the patients with a "duration of ≤10 days intensive unit care (ICU) stay" and patients with a "duration of >10 days ICU stay". ----- Results: No association between any lipid/lipoprotein parameter and the severity of COVID-19 could be found but survivors and non-survivors did differ concerning total cholesterol and LDL-C levels. ----- Conclusion: Multivariate cox regression analysis could not prove any association between lipids/lipoproteins and severe events in COVID-19 patients. Significantly less non-survivors with COVID-19 were taking atorvastatin than survivors which is consistent with the majority of previous findings.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleClinical Nutrition ESPEN
Numberingvol. 49, pp. 191-196
p-ISSN2405-4577
DOIhttps://doi.org/10.1016/j.clnesp.2022.04.026
URN:NBNurn:nbn:hr:105:761856
Publication2022-06
Document URLhttps://linkinghub.elsevier.com/retrieve/pii/S2405457722002522
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2022-12-15 08:08:32